Hendrickson & Long PLLC

West Virginia

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases3

Challenger50%

Patent Owner50%

NPE50%

hendrickson-long

handl.com

Practice Areas

Biotech

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
09/16/24	Regeneron Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 1:22-CV-00061 ( N.D. WV )	ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024)
07/16/24	1:24-MD-03103 ( N.D. WV )	USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 258 in 1:24-md-03103-TSK-JPM and 268 in 1:23-cv-00094-TSK-JPM. Notice of Appeal filed by Samsung Bioepis, CO., LTD. Federal Circuit USCA Case Number: 2024-2083. (snc) (Entered: 07/16/2024)
07/16/24	1:24-MD-03103 ( N.D. WV )	USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 250 in 1:23-cv-00106-TSK-JPM and 259 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Samsung Bioepis Co., Ltd. Federal Circuit USCA Case Number: 2024-2082. (snc) (Entered: 07/16/2024)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	NOTICE of Appearance by Gordon H. Copland on behalf of Kindeva Drug Delivery L.P., Mylan Pharmaceuticals Inc. (Copland, Gordon) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	REPORT to USPTO on the filing or determination of an action regarding re 1 Complaint. (kam) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	Report on the Filing or Determination of an Action Regarding a Patent or Trademark Other Document filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Law, Sandra) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA) Other Document filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Law, Sandra) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	Corporate Disclosure Statement by Astrazeneca Pharmaceuticals LP identifying Corporate Parent AstraZeneca PLC for Astrazeneca Pharmaceuticals LP.. (Law, Sandra) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	Corporate Disclosure Statement by AstraZeneca AB identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB.. (Law, Sandra) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	Exhibit B Other Document re 1 Complaint filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Law, Sandra) (Entered: 04/26/2022)